Index -
P/E -
EPS (ttm) -0.53
Insider Own 26.12%
Shs Outstand 406.39M
Perf Week 12.34%
Market Cap 2.50B
Forward P/E -
EPS next Y -0.15
Insider Trans 0.02%
Shs Float 302.58M
Perf Month -4.09%
Income -215.05M
PEG -
EPS next Q -0.01
Inst Own 85.79%
Short Float 15.52%
Perf Quarter -51.36%
Sales 4.56B
P/S 0.55
EPS this Y 34.66%
Inst Trans 1.83%
Short Ratio 7.71
Perf Half Y -66.83%
Book/sh 1.63
P/B 3.75
EPS next Y 52.31%
ROA -11.59%
Short Interest 46.96M
Perf Year -77.59%
Cash/sh 1.21
P/C 5.05
EPS next 5Y -
ROE -23.40%
52W Range 4.44 - 28.99
Perf YTD -51.39%
Dividend Est. -
P/FCF -
EPS past 5Y 7.65%
ROI -30.50%
52W High -78.96%
Beta 0.48
Dividend TTM -
Quick Ratio 1.51
Sales past 5Y 53.71%
Gross Margin 1.10%
52W Low 37.39%
ATR (14) 0.44
Dividend Ex-Date -
Current Ratio 1.51
EPS Y/Y TTM -104.64%
Oper. Margin -5.19%
RSI (14) 54.53
Volatility 10.30% 7.14%
Employees 1117
Debt/Eq 0.08
Sales Y/Y TTM 68.26%
Profit Margin -4.72%
Recom 2.38
Target Price 7.54
Option/Short Yes / Yes
LT Debt/Eq 0.07
EPS Q/Q -228.39%
Payout -
Rel Volume 0.78
Prev Close 5.73
Sales Surprise 1.90%
EPS Surprise -48.01%
Sales Q/Q 53.10%
Earnings Feb 27 AMC
Avg Volume 6.09M
Price 6.10
SMA20 9.34%
SMA50 -0.24%
SMA200 -54.83%
Trades
Volume 4,747,813
Change 6.46%
Date
Action
Analyst
Rating Change
Price Target Change
Mar-06-24 Initiated
Barclays
Underweight
$5
Feb-26-24 Downgrade
TD Cowen
Outperform → Market Perform
$12 → $6.50
Feb-26-24 Downgrade
Jefferies
Buy → Hold
$25 → $6.50
Jan-08-24 Downgrade
Wolfe Research
Outperform → Peer Perform
Jan-08-24 Downgrade
Stifel
Buy → Hold
Jan-08-24 Downgrade
Leerink Partners
Outperform → Market Perform
Jan-05-24 Downgrade
Truist
Buy → Hold
$23 → $10
Jan-05-24 Downgrade
JP Morgan
Overweight → Neutral
Dec-11-23 Downgrade
Goldman
Buy → Neutral
$14
Dec-06-23 Initiated
JMP Securities
Mkt Outperform
$18
Nov-21-23 Downgrade
Deutsche Bank
Buy → Hold
$27 → $12
Oct-20-23 Initiated
The Benchmark Company
Buy
$28
Jun-13-23 Initiated
Evercore ISI
In-line
$22.50
Dec-09-22 Initiated
Stifel
Buy
$23
Sep-14-22 Initiated
RBC Capital Mkts
Outperform
$33
Sep-12-22 Initiated
Goldman
Buy
$38
Sep-07-22 Resumed
Truist
Buy
$33 → $29
Jun-24-22 Initiated
BTIG Research
Neutral
Mar-30-22 Initiated
Guggenheim
Buy
$32
Oct-20-21 Initiated
Jefferies
Buy
$35
Show Previous Ratings
Mar-08-24 01:33AM
Feb-28-24 10:23AM
Feb-27-24 06:00PM
05:20PM
04:44PM
04:28PM
Loading…
04:28PM
(Associated Press Finance)
04:00PM
09:00AM
Feb-26-24 09:16AM
Feb-21-24 04:00PM
Feb-20-24 10:00AM
Feb-09-24 04:00PM
Feb-08-24 04:00PM
Feb-06-24 02:57PM
Jan-26-24 09:00PM
05:26AM
Loading…
Jan-09-24 05:26AM
Jan-05-24 01:09PM
10:39AM
06:05AM
06:00AM
Jan-03-24 11:46AM
Dec-21-23 04:00PM
Dec-01-23 12:21PM
09:05AM
Nov-07-23 04:00PM
Nov-06-23 10:08AM
Nov-02-23 07:04PM
05:30PM
04:00PM
Nov-01-23 04:00PM
04:10PM
Loading…
Oct-23-23 04:10PM
Oct-11-23 04:30PM
Sep-14-23 01:28PM
Aug-24-23 04:01PM
Aug-03-23 10:30PM
05:15PM
04:11PM
(Associated Press Finance)
04:00PM
Jul-27-23 12:18PM
Jul-12-23 04:05PM
Jun-26-23 08:30AM
Jun-22-23 09:00AM
Jun-12-23 10:12AM
May-31-23 08:30AM
May-29-23 09:06AM
May-25-23 04:30PM
May-16-23 02:15AM
May-15-23 04:18PM
May-09-23 05:35PM
04:27PM
04:01PM
May-08-23 06:35AM
May-03-23 04:15PM
May-02-23 08:30AM
Apr-26-23 05:46AM
Apr-20-23 04:21PM
Apr-17-23 10:03AM
Mar-31-23 08:42AM
Mar-30-23 07:30AM
07:30AM
Mar-20-23 07:48AM
Mar-15-23 04:15PM
Mar-06-23 01:07AM
Mar-01-23 05:15PM
04:01PM
04:00PM
Feb-28-23 08:30AM
Feb-22-23 08:30AM
Feb-17-23 10:50AM
Feb-15-23 08:30AM
Feb-09-23 08:33AM
Jan-31-23 04:30PM
Jan-24-23 08:30AM
Dec-21-22 04:15PM
Dec-19-22 08:35AM
Nov-07-22 04:15PM
Nov-03-22 07:45PM
04:10PM
Oct-10-22 04:15PM
01:20PM
Sep-10-22 10:39AM
Sep-04-22 10:00AM
(The Wall Street Journal)
Aug-29-22 04:15PM
Aug-10-22 04:33PM
Aug-09-22 09:00AM
Aug-07-22 08:14AM
Aug-05-22 04:00AM
Aug-04-22 04:10PM
Jul-12-22 04:15PM
08:04AM
Jul-11-22 01:16PM
(Investor's Business Daily)
Jun-28-22 09:00AM
Jun-01-22 04:15PM
May-31-22 10:27AM
May-05-22 04:15PM
May-03-22 12:40PM
08:30AM
May-02-22 08:31PM
04:00PM
Apr-12-22 05:00PM
Agilon Health, Inc. engages in providing healthcare services. It also provides the technology, people, capital, process, and access to a peer network of primary care physicians. The company was founded by Ronald A. Williams and Veeral Desai in 2016 and is headquartered in Austin, TX.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
WILLIAMS RONALD A Director Jan 05 '24 Option Exercise 1.27 1,100,000 1,400,000 3,564,414 Jan 09 04:54 PM Schwaneke Jeffrey A. Director Nov 29 '23 Buy 11.22 22,300 250,206 31,931 Nov 30 05:04 PM Shaker Benjamin Chief Markets Officer Sep 13 '23 Option Exercise 3.79 18,750 71,062 98,293 Sep 14 04:37 PM Shaker Benjamin Chief Markets Officer Sep 13 '23 Sale 18.00 18,750 337,455 79,543 Sep 14 04:37 PM Shaker Benjamin Chief Markets Officer Sep 12 '23 Option Exercise 3.79 18,750 71,062 98,293 Sep 14 04:37 PM Shaker Benjamin Chief Markets Officer Sep 12 '23 Sale 18.05 18,750 338,481 79,543 Sep 14 04:37 PM Gertsch Timothy Chief Accounting Officer Sep 11 '23 Option Exercise 7.49 26,250 196,700 34,621 Sep 13 06:03 PM Gertsch Timothy Chief Accounting Officer Sep 11 '23 Sale 18.61 26,250 488,616 17,121 Sep 13 06:03 PM Shaker Benjamin Chief Markets Officer Aug 15 '23 Option Exercise 3.79 18,750 71,062 98,293 Aug 16 04:17 PM Shaker Benjamin Chief Markets Officer Aug 15 '23 Sale 18.10 18,750 339,309 79,543 Aug 16 04:17 PM Shaker Benjamin Chief Markets Officer Aug 14 '23 Option Exercise 3.79 18,750 71,062 98,293 Aug 16 04:17 PM Shaker Benjamin Chief Markets Officer Aug 14 '23 Sale 18.72 18,750 351,082 79,543 Aug 16 04:17 PM Shaker Benjamin Chief Markets Officer Jul 13 '23 Option Exercise 3.79 18,750 71,062 98,293 Jul 14 04:28 PM Shaker Benjamin Chief Markets Officer Jul 13 '23 Sale 16.93 18,750 317,424 79,543 Jul 14 04:28 PM Shaker Benjamin Chief Markets Officer Jul 12 '23 Option Exercise 3.79 18,750 71,062 98,293 Jul 14 04:28 PM Shaker Benjamin Chief Markets Officer Jul 12 '23 Sale 16.97 18,750 318,182 79,543 Jul 14 04:28 PM Shaker Benjamin Chief Markets Officer Jun 15 '23 Option Exercise 3.79 18,750 71,062 98,293 Jun 16 04:14 PM Shaker Benjamin Chief Markets Officer Jun 15 '23 Sale 18.73 18,750 351,103 79,543 Jun 16 04:14 PM Shaker Benjamin Chief Markets Officer Jun 14 '23 Option Exercise 3.71 18,750 69,600 95,342 Jun 16 04:14 PM Shaker Benjamin Chief Markets Officer Jun 14 '23 Sale 18.57 18,750 348,146 79,543 Jun 16 04:14 PM CD&R Investment Associates IX, 10% Owner May 18 '23 Sale 20.80 94,173,804 1,958,937,549 100,000,000 May 18 04:05 PM Shaker Benjamin Chief Markets Officer May 16 '23 Option Exercise 3.00 25,000 75,000 104,543 May 17 04:46 PM Shaker Benjamin Chief Markets Officer May 16 '23 Sale 23.14 25,000 578,535 79,543 May 17 04:46 PM Shaker Benjamin Chief Markets Officer May 15 '23 Option Exercise 3.00 25,000 75,000 104,543 May 17 04:46 PM Shaker Benjamin Chief Markets Officer May 15 '23 Sale 23.79 25,000 594,732 79,543 May 17 04:46 PM Desai Veeral Chief Strategy & Dev. Officer May 09 '23 Option Exercise 3.00 4,500 13,500 304,085 May 11 04:52 PM Desai Veeral Chief Strategy & Dev. Officer May 09 '23 Sale 26.15 4,500 117,666 299,585 May 11 04:52 PM Desai Veeral Chief Strategy & Dev. Officer Apr 20 '23 Option Exercise 3.00 500 1,500 300,085 Apr 21 04:03 PM Desai Veeral Chief Strategy & Dev. Officer Apr 20 '23 Sale 26.15 500 13,074 299,585 Apr 21 04:03 PM Desai Veeral Chief Strategy & Dev. Officer Apr 19 '23 Option Exercise 3.00 5,000 15,000 304,585 Apr 21 04:03 PM Desai Veeral Chief Strategy & Dev. Officer Apr 19 '23 Sale 26.91 5,000 134,544 299,585 Apr 21 04:03 PM Shaker Benjamin Chief Markets Officer Apr 18 '23 Option Exercise 3.00 25,000 75,000 104,543 Apr 19 05:35 PM Shaker Benjamin Chief Markets Officer Apr 18 '23 Sale 28.05 25,000 701,130 79,543 Apr 19 05:35 PM Shaker Benjamin Chief Markets Officer Apr 17 '23 Option Exercise 2.85 25,000 71,298 104,543 Apr 19 05:35 PM Shaker Benjamin Chief Markets Officer Apr 17 '23 Sale 27.74 25,000 693,597 79,543 Apr 19 05:35 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite